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Supporting Materials and Methods
Cell viability assay
The cytotoxic effects of the PIs against the MM cell lines were determined by using the MTT reagent (Sigma-Aldrich). Specifically, 8,000 cells per well were plated in flat-bottomed 96-well plates with the use of phenol red free RPMI 1640 medium (Lonza), in the presence (or not) of different concentrations of PIs, MAPK and STAT inhibitors or the MTH1 inhibitor. The final volume was adjusted to 100 μl per well. The plates were transferred in a humidified incubator for 24 h at 37°C.
Subsequently, 10 μl of MTT solution (5 mg/ml in PBS) was added in each well. After 3 to 4 h of incubation, 100 μl of solubilization solution (10% SDS in 0.01N HCl) was added to dissolve the formazan crystals and the plates were incubated overnight at 37°C. Plates were then sufficiently stirred and the optical density (OD) at 570 nm wavelength was measured. The percentage of cell viability was calculated by setting OD obtained by control samples (absence of PIs) to 100%.
Measurement of proteasome peptidases activities
For proteasome activities measurement, cells were plated in 35 mm petri dishes at a concentration of 500,000 cells per ml, in the presence (or not) of the selected concentrations of PIs. After 24 h to 48 h treatment, cells were collected, lysed on ice and proteasome activities were measured as described before 18 . The values obtained by control samples (no PI addition) were set as 100% peptidase activity.
Immunoblotting analysis and antibodies used
Immunoblotting analysis was performed in cell culture supernatants and in cell lysates as described before 18 . Primary antibodies against p-STAT3 (9145) and p-STAT6 (9361), as well as against IL6 (500-P26G) were purchased from Cell Signaling Technology and PeproTech, Inc, respectively. The antibodies against IL8 (sc-376750), CXCL10 (sc-101500) and GAPDH (sc-25778) were obtained from Santa Cruz Biotechnology. The secondary HRP-conjugated IgG antibody was purchased from Jackson ImmunoResearch Laboratories, Inc.
